Director Albert Cha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) issued its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.76) by ($0.04), MarketWatch Earnings reports. KalVista Pharmaceuticals Stock Performance Shares of NASDAQ KALV opened at $8.16 on Friday. The company has a 50 […]

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $10.21 and traded as low as $8.96. KalVista Pharmaceuticals shares last traded at $9.25, with a volume of 120,390 shares traded. Analysts Set New Price […]